702 related articles for article (PubMed ID: 32080373)
1. Current approaches to the management of brain metastases.
Suh JH; Kotecha R; Chao ST; Ahluwalia MS; Sahgal A; Chang EL
Nat Rev Clin Oncol; 2020 May; 17(5):279-299. PubMed ID: 32080373
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review.
Buczek D; Zaucha R; Jassem J
Front Oncol; 2023; 13():1215426. PubMed ID: 38370347
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
4. [Management of brain metastases in 2022].
Schiappacasse L; Kinj R; De Micheli R; Mederos N; Tuleasca C; Cossu G; Dunet V; Levivier M; Bourhis J; Hottinger AF
Rev Med Suisse; 2022 May; 18(782):976-983. PubMed ID: 35583276
[TBL] [Abstract][Full Text] [Related]
5. Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases.
Jiang C; Wallington DG; Anker CJ; Lawson DH; Yushak ML; Kudchadkar RR; Tarhini A; Khan MK
Neurosurgery; 2020 Sep; 87(3):498-515. PubMed ID: 32315430
[TBL] [Abstract][Full Text] [Related]
6. Targeted and immunotherapeutic approaches in brain metastases.
Ahluwalia MS; Winkler F
Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of brain metastases: current knowledge and new frontiers.
Neagu MR; Gill CM; Batchelor TT; Brastianos PK
Chin Clin Oncol; 2015 Jun; 4(2):22. PubMed ID: 26112808
[TBL] [Abstract][Full Text] [Related]
8. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
9. [Melanoma brain metastases : Treatment options].
Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
[TBL] [Abstract][Full Text] [Related]
10. Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
Press RH; Prabhu RS; Nickleach DC; Liu Y; Shu HK; Kandula S; Patel KR; Curran WJ; Crocker I
Cancer; 2015 Nov; 121(21):3836-43. PubMed ID: 26242475
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.
Lazaro T; Brastianos PK
CNS Oncol; 2017 Apr; 6(2):139-151. PubMed ID: 28425754
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future Trials.
Zhang I; Formenti SC; Knisely JPS
Oncology (Williston Park); 2018 Mar; 32(3):e33-e37. PubMed ID: 29548066
[TBL] [Abstract][Full Text] [Related]
13. Neurosurgical and radiosurgical decision making in brain metastasis patients in the area of targeted therapies?
Metellus P; Bialecki E; Le Rhun E; Dhermain F
Chin Clin Oncol; 2015 Jun; 4(2):19. PubMed ID: 26112805
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
Zhang I; Formenti SC; Knisely JPS
Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
[TBL] [Abstract][Full Text] [Related]
16. Current treatment paradigms for the management of patients with brain metastases.
Ewend MG; Elbabaa S; Carey LA
Neurosurgery; 2005 Nov; 57(5 Suppl):S66-77; discusssion S1-4. PubMed ID: 16237291
[TBL] [Abstract][Full Text] [Related]
17. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
Zubatkina I; Ivanov P
J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116
[TBL] [Abstract][Full Text] [Related]
18. Targeted Therapies for Brain Metastases.
Niranjan A; Lunsford LD; Ahluwalia MS
Prog Neurol Surg; 2019; 34():125-137. PubMed ID: 31096209
[TBL] [Abstract][Full Text] [Related]
19. Sequencing brain metastases and opportunities for targeted therapies.
Chukwueke UN; Brastianos PK
Pharmacogenomics; 2017 Apr; 18(6):585-594. PubMed ID: 28290769
[TBL] [Abstract][Full Text] [Related]
20. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
